Breaking News

The latest on a push to wield march-in rights; president of generic drug lobby ousted

   

 

Pharmalot Ed Silverman

STAT+: A year after petition, NIH will finally review request to lower cancer drug's cost by sidestepping patents

By Ed Silverman

Adobe

“A rejection of the petition will encourage more aggressive pricing of drugs," wrote two cancer patients to the HHS.

Read More

STAT+: AAM's Dan Leonard, president of generic drug lobby, ousted

By John Wilkerson

Adobe

The generic drug industry’s lobbying group, the Association for Accessible Medicines, fired its president Dan Leonard, three sources said.

Read More

STAT+: The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor

By Bob Herman

Adobe

UnitedHealth Group expects to funnel more of the insurance premiums it collects from workers and taxpayers toward itself next year.

Read More

Opinion: Congress needs to update FDA's ability to regulate diagnostic tests, cosmetics

By Scott Gottlieb and Mark B. McClellan

ARIS MESSINIS/AFP via Getty Images

By passing proposed legislation, Congress would help the FDA gain better oversight of diagnostic tests and cosmetics.

Read More

Medical malpractice lawsuits, delayed by the pandemic, are hitting hospitals harder than expected

By Tara Bannow

Adobe

Medical malpractice lawsuits were held up as court dockets ground to a halt during the pandemic. Now, they're catching up with hospitals.

Read More

Monday, December 5, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments